Physician

Holly S Carobene, M.D.

According to 2025 Medicare claims, Holly Carobene, M.D. (NPI: 1326140633) practices interventional pain management (ipm) in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Mc Henry, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60014-8003. Carobene is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620) and Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Carobene's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 451 traditional Medicare patients, billed 5,510 HCPCS/CPT codes, and received $135,525 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 842 prescription claims across 235 beneficiaries totaling $11,386 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $357,908 to $135,525. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $77,293 to $11,386. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	569	12,833	$357,908
2016	550	12,358	$333,712
2017	548	7,193	$178,150
2018	500	3,022	$146,506
2019	501	3,474	$171,407
2020	399	3,704	$135,023
2021	457	3,886	$154,714
2022	610	3,241	$156,768
2023	528	4,103	$146,277
2024	451	5,510	$135,525

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	225	1,480	$77,293
2016	212	1,719	$123,942
2017	197	1,393	$96,124
2018	136	750	$23,143
2019	168	779	$21,118
2020	179	853	$24,915
2021	215	799	$13,940
2022	251	851	$16,773
2023	266	820	$17,870
2024	235	842	$11,386

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	126	126	$122
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	56	67	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	271	440	$89
62323	Injection of substance into lower spine canal using imaging guidance	162	194	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	63	71	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	301	10,084	$3,571
Pregabalin	Pregabalin	129	4,470	$2,126
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	2,387	$1,938
Methylprednisolone	Methylprednisolone	125	749	$679
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	307	$650

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Holly S. Carobene, M.D.?

Tedicare shows public-source Medicare data for Holly S. Carobene, M.D. (NPI 1326140633), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Holly S. Carobene, M.D. have ACO affiliation data?

Holly S. Carobene, M.D. is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620) and Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Holly S. Carobene, M.D.?

Holly S. Carobene, M.D. is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Holly S. Carobene, M.D. have Open Payments data?

Holly S. Carobene, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.